P3 Health Partners (PIII)
(Delayed Data from NSDQ)
$6.70 USD
-0.13 (-1.90%)
Updated Aug 8, 2025 03:02 PM ET
After-Market: $6.38 -0.32 (-4.78%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PIII 6.70 -0.13(-1.90%)
Will PIII be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PIII based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PIII
Enovis (ENOV) Beats Q2 Earnings and Revenue Estimates
KORU Medical Systems, Inc. (KRMD) Reports Break-Even Earnings for Q2
PIII: What are Zacks experts saying now?
Zacks Private Portfolio Services
MDxHealth SA (MDXH) Reports Q2 Loss, Tops Revenue Estimates
Bears are Losing Control Over P3 Health Partners (PIII), Here's Why It's a 'Buy' Now
Down 18.4% in 4 Weeks, Here's Why You Should You Buy the Dip in P3 Health Partners (PIII)
Other News for PIII
P3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference Call | PIII ...
12 Health Care Stocks Moving In Wednesday's Intraday Session
P3 Health Partners (PIII) Resumes Trading on the Market
Trading Paused for P3 Health Partners (PIII) Due to Market Volatility
P3 Health Partners Inc trading resumes